FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009257411> ?p ?o ?g. }

• W2009257411 endingPage "389" @default.
• W2009257411 startingPage "386" @default.
• W2009257411 abstract "Recently in the Journal of Neuro-Ophthalmology, we discussed the potential efficacy of idebenone, a coenzyme Q derivative that acts as a carrier in the mitochondrial electron transport chain, in treating patients with Leber hereditary optic neuropathy (LHON) (1). Within the past 2 decades, Wolfram syndrome (WS) has been mapped to chromosome 4p16.1 (2) and is thought to harbor a mitochondrial genome deletion (3,4) or complex III deficiency (5). The only current treatment for this devastating disease is limited to blood sugar control with lower doses of insulin compared with patients with diabetes mellitus (DM). We had the opportunity to treat a patient with WS with idebenone, hoping for improvement in visual function. A 21-year-old Romanian man was initially evaluated 5 years previously with progressive bilateral visual and hearing loss and a neurogenic bladder. Surgical history was significant for bilateral cataract extractions with intraocular lens implants at 11 years of age. Medications included insulin and effexor. Family history was significant for DM in both parents, without a history of hearing or visual loss. Genetic testing confirmed the diagnosis of WS with the mutation of the WFS1 Wolframin gene. The patient was overweight but appeared younger than his stated age. Visual acuity was light perception to bare hand motion bilaterally. Pupils were sluggishly reactive without a relative afferent pupillary defect. Intraocular pressures were normal and funduscopy revealed bilateral optic disc pallor (Fig. 1). Spectral domain optical coherence tomography (OCT) showed marked thinning of the retinal nerve fiber layer in each eye (Fig. 2). The patient had bilateral sensorineural hearing loss of higher frequency sounds with preservation of hearing lower frequencies. He was prescribed idebenone that was gradually increased from 150 mg daily to 150 mg twice a day at 2 months, and then to 150 mg 3 times a day at 4 months.FIG. 1: Bilateral optic atrophy in our patient with Wolfram syndrome.FIG. 2: Spectral domain optical coherence tomography demonstrates severe thinning of retinal nerve fiber layer in each eye, most prominently in the superior and inferior quadrants.At 3 months, the patient’s vision improved to hand motions at 1 foot bilaterally. At 6 months, visual acuity was hand motions at 2 feet, right eye, and hand motions at 4 feet, left eye. Ophthalmoscopic and OCT findings remained unchanged. Our patient had difficulty with standard kinetic visual field testing given his poor vision (Fig. 3). To enhance light intensity of the stimulus, we used green and red laser stimuli rather than white. We were able to quantitate the visual field using a kinetic technique with these colored stimuli (Fig. 2). The patient could see the brighter more intense green stimulus, with some false positives with the red stimulus, whereas he previously was unable to detect any such stimulus on visual field testing.FIG. 3: Kinetic visual field testing demonstrates the patient’s ability to detect high-intensity green stimulus (A) and less intense red stimulus (B). The dots in the visual field (B) represent areas that the patient initially recognized but failed to do so when re-tested.Recent publications describe the use of idebenone, a coenzyme Q10 derivative, in the treatment of LHON (1,7,8). Given that WS has features of mitochondrial dysfunction, we decided to initiate idebenone treatment. In our patient, idebenone resulted in progressive but subjective visual recovery at 6 months. Similarly, in reports of response to idebenone in LHON, the effects usually do not begin until after 6 months (1,7). This long-term recovery may relate to potentiation of axonal action potentials (9). Carelli et al (10) demonstrated histologically that intact axons with poor myelination showed occasional remyelination, which may occur during the course of idebenone treatment. This finding suggests that there may be a subset of axons that, with remodeling of myelin, acquire a functionally useful firing pattern, and potential for visual improvement with time. Our patient with WS seems to have experienced some visual recovery with idebenone treatment. A prospective study using idebenone in patients with WS will be necessary to define the efficacy of this therapy." @default.
• W2009257411 created "2016-06-24" @default.
• W2009257411 creator A5020006065 @default.
• W2009257411 creator A5050345876 @default.
• W2009257411 creator A5065390232 @default.
• W2009257411 creator A5089657195 @default.
• W2009257411 date "2012-12-01" @default.
• W2009257411 modified "2023-10-16" @default.
• W2009257411 title "Visual Improvement With the Use of Idebenone in the Treatment of Wolfram Syndrome" @default.
• W2009257411 cites W1991133204 @default.
• W2009257411 cites W2009508960 @default.
• W2009257411 cites W2035877471 @default.
• W2009257411 cites W2049808069 @default.
• W2009257411 cites W2058837644 @default.
• W2009257411 cites W2094177935 @default.
• W2009257411 cites W2109645784 @default.
• W2009257411 cites W2112785879 @default.
• W2009257411 doi "https://doi.org/10.1097/wno.0b013e318273c102" @default.
• W2009257411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23196951" @default.
• W2009257411 hasPublicationYear "2012" @default.
• W2009257411 type Work @default.
• W2009257411 sameAs 2009257411 @default.
• W2009257411 citedByCount "23" @default.
• W2009257411 countsByYear W20092574112013 @default.
• W2009257411 countsByYear W20092574112014 @default.
• W2009257411 countsByYear W20092574112016 @default.
• W2009257411 countsByYear W20092574112017 @default.
• W2009257411 countsByYear W20092574112018 @default.
• W2009257411 countsByYear W20092574112019 @default.
• W2009257411 countsByYear W20092574112020 @default.
• W2009257411 countsByYear W20092574112021 @default.
• W2009257411 countsByYear W20092574112022 @default.
• W2009257411 crossrefType "journal-article" @default.
• W2009257411 hasAuthorship W2009257411A5020006065 @default.
• W2009257411 hasAuthorship W2009257411A5050345876 @default.
• W2009257411 hasAuthorship W2009257411A5065390232 @default.
• W2009257411 hasAuthorship W2009257411A5089657195 @default.
• W2009257411 hasBestOaLocation W20092574111 @default.
• W2009257411 hasConcept C118487528 @default.
• W2009257411 hasConcept C126322002 @default.
• W2009257411 hasConcept C134018914 @default.
• W2009257411 hasConcept C141071460 @default.
• W2009257411 hasConcept C187212893 @default.
• W2009257411 hasConcept C2776391266 @default.
• W2009257411 hasConcept C2776756211 @default.
• W2009257411 hasConcept C2777056713 @default.
• W2009257411 hasConcept C2777403772 @default.
• W2009257411 hasConcept C2778233873 @default.
• W2009257411 hasConcept C2778257484 @default.
• W2009257411 hasConcept C2778527774 @default.
• W2009257411 hasConcept C2780592520 @default.
• W2009257411 hasConcept C2780837183 @default.
• W2009257411 hasConcept C2781179581 @default.
• W2009257411 hasConcept C555293320 @default.
• W2009257411 hasConcept C71924100 @default.
• W2009257411 hasConceptScore W2009257411C118487528 @default.
• W2009257411 hasConceptScore W2009257411C126322002 @default.
• W2009257411 hasConceptScore W2009257411C134018914 @default.
• W2009257411 hasConceptScore W2009257411C141071460 @default.
• W2009257411 hasConceptScore W2009257411C187212893 @default.
• W2009257411 hasConceptScore W2009257411C2776391266 @default.
• W2009257411 hasConceptScore W2009257411C2776756211 @default.
• W2009257411 hasConceptScore W2009257411C2777056713 @default.
• W2009257411 hasConceptScore W2009257411C2777403772 @default.
• W2009257411 hasConceptScore W2009257411C2778233873 @default.
• W2009257411 hasConceptScore W2009257411C2778257484 @default.
• W2009257411 hasConceptScore W2009257411C2778527774 @default.
• W2009257411 hasConceptScore W2009257411C2780592520 @default.
• W2009257411 hasConceptScore W2009257411C2780837183 @default.
• W2009257411 hasConceptScore W2009257411C2781179581 @default.
• W2009257411 hasConceptScore W2009257411C555293320 @default.
• W2009257411 hasConceptScore W2009257411C71924100 @default.
• W2009257411 hasIssue "4" @default.
• W2009257411 hasLocation W20092574111 @default.
• W2009257411 hasLocation W20092574112 @default.
• W2009257411 hasLocation W20092574113 @default.
• W2009257411 hasOpenAccess W2009257411 @default.
• W2009257411 hasPrimaryLocation W20092574111 @default.
• W2009257411 hasRelatedWork W1977417564 @default.
• W2009257411 hasRelatedWork W1981900389 @default.
• W2009257411 hasRelatedWork W2005286832 @default.
• W2009257411 hasRelatedWork W2035877471 @default.
• W2009257411 hasRelatedWork W2040049140 @default.
• W2009257411 hasRelatedWork W2120759847 @default.
• W2009257411 hasRelatedWork W2124154990 @default.
• W2009257411 hasRelatedWork W2619641465 @default.
• W2009257411 hasRelatedWork W2809382745 @default.
• W2009257411 hasRelatedWork W3089735243 @default.
• W2009257411 hasVolume "32" @default.
• W2009257411 isParatext "false" @default.
• W2009257411 isRetracted "false" @default.
• W2009257411 magId "2009257411" @default.
• W2009257411 workType "article" @default.